Pfizer Inc. (ETR:PFE)
Germany · Delayed Price · Currency is EUR | Market Cap | 115.87B |
| Revenue (ttm) | 54.48B |
| Net Income (ttm) | 9.18B |
| Shares Out | n/a |
| EPS (ttm) | 1.62 |
| PE Ratio | 12.63 |
| Forward PE | 8.43 |
| Dividend | 1.55 (7.66%) |
| Ex-Dividend Date | Jul 25, 2025 |
| Volume | 67,637 |
| Average Volume | 42,141 |
| Open | 20.37 |
| Previous Close | 20.22 |
| Day's Range | 20.24 - 20.41 |
| 52-Week Range | 18.57 - 27.77 |
| Beta | 0.46 |
| RSI | 33.07 |
| Earnings Date | Oct 28, 2025 |
About Pfizer
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]
Financial Performance
In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.
Financial numbers in USD Financial StatementsNews
Pfizer (PFE) Highlights New COVID Vaccine Data
Pfizer (PFE) Highlights New COVID Vaccine Data
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have de...
Pfizer, Moderna post data supporting COVID shots after Trump demand
CDC vaccine panel to meet this week: Here's what's at stake
Scott Gottlieb, former FDA commissioner and current board member of Pfizer and Illumina, joins CNBC's 'Squawk on the Street' to discuss expectations for a CDC panel's review of vaccines this week, wha...
PFE January 2028 Options Begin Trading
Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the January 2028 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the tim...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Validea Detailed Fundamental Analysis - PFE
Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy of Me...
Why I Sold Pfizer To Buy Novo Nordisk
While Pfizer's market cap and dividends are at risk, Novo has a strong competitive position in GLP-1 TAM. Read why I prefer NVO stock over PFE stock.
1 Reason Every Investor Should Know About Pfizer (PFE) Stock
How does $700 in annual income sound for every $10,000 in shares owned?
Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine
Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively.
Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths
Shares of COVID-19 vaccine makers Pfizer Inc (NYSE: PFE), BioNTech SE ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) are trading lower Friday following a Washington Post report that Trump admini...
Meet 16 Ideal "Safer" September Dividend Dogs Of The S&P500
Sixteen of the thirty-eight highest-yield, 'safer' S&P 500 dividend stocks are highlighted as ready to buy, with adequate free cash flow supporting payouts. Analyst forecasts suggest top ten S&P 500 d...
COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says
Shares of companies that make COVID vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths.
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
The report says officials plan to include the claim in a presentation next week to a key vaccine panel that advises the CDC on shot access and coverage.
Trump officials to link child deaths to covid shots, according to reports
CNBC's Angelica Peebles joins 'Money Movers' to discuss Trump officials reported plan to link child deaths to covid shots.
BridgeBio (BBIO) Challenges Pfizer's ATTR-CM Promotion Tactics
BridgeBio (BBIO) Challenges Pfizer's ATTR-CM Promotion Tactics
OLMA Stock Soars 47% in September So Far on Second PFE Deal
Olema Pharmaceuticals surges 47% in September after striking a second collaboration with Pfizer for its lead breast cancer product candidate, palazestrant.
Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects
Pfizer's late-stage pipeline, from oncology blockbusters to mRNA vaccines, positions it for long-term growth despite recent setbacks.
Trump Urges Pharma Giants Including PFE to Cut U.S. Drug Prices
Trump Urges Pharma Giants Including PFE to Cut U.S. Drug Prices
Pfizer, Alnylam earn BridgeBio ire over sales tactics for amyloidosis drugs: Bloomberg
Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl
Pfizer's Comeback Accelerates
Pfizer achieved 10% year-over-year Q2 2025 revenue growth to $14.7 billion, driven by Abrysvo RSV vaccine and Seagen-acquired oncology assets. Management expects over $20 billion in risk-adjusted reve...
US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says
The impact of U.S. President Donald Trump's plan to levy import duties on pharmaceutical products and his push to lower drug prices are likely to be manageable for big U.S. and European drugmakers, ac...
Trump's Going After Prescription Drug Ads. What It Means for Pharmaceutical Sales.
The effort falls well short of banning the ads outright, but could dent sales.